NAMS
Price
$33.28
Change
-$1.98 (-5.62%)
Updated
Jul 13 closing price
Capitalization
3.89B
29 days until earnings call
Intraday BUY SELL Signals
PTGX
Price
$129.89
Change
-$1.53 (-1.16%)
Updated
Jul 13 closing price
Capitalization
8.35B
16 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NAMS vs PTGX

NAMS vs PTGX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NAMS vs. PTGX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAMS is a Buy and PTGX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (NAMS: $33.28 vs. PTGX: $129.89)
Brand notoriety: NAMS and PTGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAMS: 19% vs. PTGX: 39%
Market capitalization -- NAMS: $3.89B vs. PTGX: $8.35B
NAMS [@Biotechnology] is valued at $3.89B. PTGX’s [@Biotechnology] market capitalization is $8.35B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAMS’s FA Score shows that 2 FA rating(s) are green whilePTGX’s FA Score has 2 green FA rating(s).

  • NAMS’s FA Score: 2 green, 3 red.
  • PTGX’s FA Score: 2 green, 3 red.
According to our system of comparison, both NAMS and PTGX are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAMS’s TA Score shows that 4 TA indicator(s) are bullish while PTGX’s TA Score has 6 bullish TA indicator(s).

  • NAMS’s TA Score: 4 bullish, 7 bearish.
  • PTGX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PTGX is a better buy in the short-term than NAMS.

Price Growth

NAMS (@Biotechnology) experienced а -4.64% price change this week, while PTGX (@Biotechnology) price change was -1.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

NAMS is expected to report earnings on Aug 12, 2026.

PTGX is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTGX($8.35B) has a higher market cap than NAMS($3.89B). PTGX YTD gains are higher at: 48.718 vs. NAMS (-5.131). PTGX has higher annual earnings (EBITDA): -141.02M vs. NAMS (-214.95M). NAMS has more cash in the bank: 636M vs. PTGX (548M). NAMS has less debt than PTGX: NAMS (23K) vs PTGX (9.78M). PTGX has higher revenues than NAMS: PTGX (74.1M) vs NAMS (22.6M).
NAMSPTGXNAMS / PTGX
Capitalization3.89B8.35B47%
EBITDA-214.95M-141.02M152%
Gain YTD-5.13148.718-11%
P/E RatioN/A133.92-
Revenue22.6M74.1M30%
Total Cash636M548M116%
Total Debt23K9.78M0%
FUNDAMENTALS RATINGS
PTGX: Fundamental Ratings
PTGX
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
21
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NAMSPTGX
RSI
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 1 day ago
75%
Momentum
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 20 days ago
81%
Bullish Trend 12 days ago
75%
Declines
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
76%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
NAMS
Daily Signal:
Gain/Loss:
PTGX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IBO0.460.02
+4.75%
Impact BioMedical Inc.
CUBE40.610.42
+1.05%
CubeSmart
MBINN20.070.13
+0.65%
Merchants Bancorp
PERI9.33-0.03
-0.32%
Perion Network Ltd
GLUE21.98-1.06
-4.60%
Monte Rosa Therapeutics